Enterohaemorrhagic Escherichia coli in human medicine

被引:508
作者
Karch, H
Tarr, PI
Blelaszewska, M
机构
[1] Univ Hosp Munster, Inst Hyg, D-48149 Munster, Germany
[2] Univ Hosp Munster, Natl Consulting Lab Haemolyt Uraem Syndrome, D-48149 Munster, Germany
[3] Washington Univ, Sch Med, Dept Paediat, St Louis, MO USA
[4] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
关键词
enterohaemorrhagic Escherichia coli; haemolytic uraemic syndrome; diarrhoea; EHEC O157 : H7; EHEC non-O157;
D O I
10.1016/j.ijmm.2005.06.009
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Enterohaemorrhagic Escherichia coli (EHEC) are the pathogenic subgroup of Shiga toxin (Stx)-producing E. coli. EHEC can cause non-bloody and bloody diarrhoea, and the haemolytic uraemic syndrome (HUS). HUS is a major cause of acute renal failure in children. E. coli O157:H7 is the predominant, but far from being the only, serotype that can cause HUS. The cascade leading from gastrointestinal infection to renal impairment is complex, with the microvascular endothelium being the major histopathological target. EHEC also produce non-Stx molecules, such as cytolethal distending toxin, which can contribute to the endothelial or vascular injury. Because there are no specific therapies for EHEC infections, efficient reservoir and human preventive strategies are important areas of ongoing investigations. This review will focus on the microbiology, epidemiology, and pathophysiology of EHEC-associated diseases, and illustrate future challenges and opportunities for their control. (c) 2005 Elsevier GmbH. All rights reserved.
引用
收藏
页码:405 / 418
页数:14
相关论文
共 141 条
  • [1] Alishahiha M, 2000, J HIGH ENERGY PHYS
  • [2] Allerberger F, 2000, WIEN KLIN WOCHENSCHR, V112, P846
  • [3] Allerberger Franz, 2003, International Journal of Infectious Diseases, V7, P42, DOI 10.1016/S1201-9712(03)90041-5
  • [4] A large outbreak of hemolytic uremic syndrome caused by an unusual sorbitol-fermenting strain of Escherichia coli O157:H-
    Ammon, A
    Petersen, LR
    Karch, H
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (05) : 1274 - 1277
  • [5] Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy - Proceedings of the American Society of Pediatric Nephrology Educational Symposium, May 2000, Boston, Massachusetts, USA
    Andreoli, SP
    Trachtman, H
    Acheson, DWK
    Siegler, RL
    Obrig, TG
    [J]. PEDIATRIC NEPHROLOGY, 2002, 17 (04) : 293 - 298
  • [6] The United States national prospective hemolytic uremic syndrome study: Microbiologic, serologic, clinical, and epidemiologic findings
    Banatvala, N
    Griffin, PM
    Greene, KD
    Barrett, TJ
    Bibb, WF
    Green, JH
    Wells, JG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (07) : 1063 - 1070
  • [7] Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections
    Bell, BP
    Griffin, PM
    Lozano, P
    Christie, DL
    Kobayashi, JM
    Tarr, PI
    [J]. PEDIATRICS, 1997, 100 (01) : art. no. - e12
  • [8] A MULTISTATE OUTBREAK OF ESCHERICHIA-COLI-O157-H7 ASSOCIATED BLOODY DIARRHEA AND HEMOLYTIC-UREMIC-SYNDROME FROM HAMBURGERS - THE WASHINGTON EXPERIENCE
    BELL, BP
    GOLDOFT, M
    GRIFFIN, PM
    DAVIS, MA
    GORDON, DC
    TARR, PI
    BARTLESON, CA
    LEWIS, JH
    BARRETT, TJ
    WELLS, JG
    BARON, R
    KOBAYASHI, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (17): : 1349 - 1353
  • [9] AN OUTBREAK OF DIARRHEA AND HEMOLYTIC UREMIC SYNDROME FROM ESCHERICHIA-COLI O157-H7 IN FRESH-PRESSED APPLE CIDER
    BESSER, RE
    LETT, SM
    WEBER, JT
    DOYLE, MP
    BARRETT, TJ
    WELLS, JG
    GRIFFIN, PM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (17): : 2217 - 2220
  • [10] First isolation outside Europe of sorbitol-fermenting Escherichia coli (VTEC) belonging to O group O157
    Bettelheim, KA
    Whipp, M
    Djordjevic, SP
    Ramachandran, V
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 51 (08) : 713 - 714